Cochlear Ltd
ASX:COH
Cochlear Ltd
Cash from Operating Activities
Cochlear Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cochlear Ltd
ASX:COH
|
Cash from Operating Activities
AU$430.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
5%
|
CAGR 10-Years
19%
|
|
Neurotech International Ltd
ASX:NTI
|
Cash from Operating Activities
-AU$6.3m
|
CAGR 3-Years
-110%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
Cash from Operating Activities
-AU$12.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-8%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cash from Operating Activities
-AU$7.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
Optiscan Imaging Ltd
ASX:OIL
|
Cash from Operating Activities
-AU$5.6m
|
CAGR 3-Years
-115%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-23%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cash from Operating Activities
AU$834.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cochlear Ltd's Cash from Operating Activities?
Cash from Operating Activities
430.4m
AUD
Based on the financial report for Dec 31, 2023, Cochlear Ltd's Cash from Operating Activities amounts to 430.4m AUD.
What is Cochlear Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
19%
Over the last year, the Cash from Operating Activities growth was 26%.